We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$995M
AUM Growth
+$58.3M
Cap. Flow
+$1.53M
Cap. Flow %
0.15%
Top 10 Hldgs %
31.03%
Holding
293
New
25
Increased
75
Reduced
95
Closed
36

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$11.7M
2
Y
Alleghany Corp
Y
+$6.27M
3
AON icon
Aon
AON
+$4.05M
4
MTRX icon
Matrix Service
MTRX
+$3.45M
5
SON icon
Sonoco
SON
+$2.78M

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$11.3M
2
AGN
Allergan plc
AGN
+$5.47M
3
COHR icon
Coherent
COHR
+$2.22M
4
MET icon
MetLife
MET
+$2.02M
5
MOS icon
The Mosaic Company
MOS
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 21.63%
2 Industrials 15.17%
3 Healthcare 14.09%
4 Financials 13.25%
5 Consumer Discretionary 12.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLW icon
1
Corning
GLW
$126B
$46.2M 4.64%
1,543,976
-12,366
-0.8% -$366K
BMY icon
2
Bristol-Myers Squibb
BMY
$127B
$37.5M 3.77%
587,890
+5,298
+0.9% +$309K
INTC icon
3
Intel
INTC
$466B
$34.4M 3.46%
904,360
-283
-0% -$10.1K
GE icon
4
GE Aerospace
GE
$367B
$34.2M 3.44%
295,381
-2,807
-0.9% -$339K
CSCO icon
5
Cisco
CSCO
$450B
$31.6M 3.18%
939,506
+3,450
+0.4% +$110K
AVY icon
6
Avery Dennison
AVY
$12.3B
$29.6M 2.97%
300,616
-1,143
-0.4% -$108K
AGN
7
DELISTED
Allergan plc
AGN
$26.9M 2.71%
131,462
-23,531
-15% -$5.47M
JCI icon
8
Johnson Controls International
JCI
$87.5B
$24.1M 2.43%
598,746
+63,456
+12% +$2.57M
XOM icon
9
ExxonMobil
XOM
$651B
$23.1M 2.32%
281,283
-7,722
-3% -$613K
JPM icon
10
JPMorgan Chase
JPM
$939B
$21M 2.11%
219,864
-340
-0.2% -$31.4K
COL
11
DELISTED
Rockwell Collins
COL
$19.2M 1.93%
146,996
-918
-0.6% -$112K
SON icon
12
Sonoco
SON
$5.76B
$18.8M 1.89%
372,928
+56,360
+18% +$2.78M
AMGN icon
13
Amgen
AMGN
$203B
$18.6M 1.87%
100,006
-1,085
-1% -$192K
TXN icon
14
Texas Instruments
TXN
$255B
$18.4M 1.85%
204,743
-504
-0.2% -$41.5K
WD icon
15
Walker & Dunlop
WD
$1.65B
$18.1M 1.82%
345,497
-13,043
-4% -$636K
CTRA
16
DELISTED
Coterra Energy
CTRA
$18.1M 1.82%
675,837
-35,035
-5% -$890K
MET icon
17
MetLife
MET
$61B
$17.3M 1.74%
332,670
-41,537
-11% -$2.02M
NWLI
18
DELISTED
National Western Life Group, Inc. Class A
NWLI
$15.8M 1.59%
45,325
-391
-0.9% -$131K
VPG icon
19
Vishay Precision Group
VPG
$1.39B
$15.5M 1.56%
636,478
-12,622
-2% -$251K
MSFT icon
20
Microsoft
MSFT
$2.84T
$15.5M 1.56%
208,110
-475
-0.2% -$34.7K
QCOM icon
21
Qualcomm
QCOM
$176B
$14.9M 1.5%
287,909
+2,705
+0.9% +$143K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.07T
$14.9M 1.5%
81,179
-569
-0.7% -$101K
KMT icon
23
Kennametal
KMT
$2.68B
$12.9M 1.3%
319,524
-44
-0% -$1.63K
DD icon
24
DuPont de Nemours
DD
$18.6B
$12.5M 1.26%
71,414
+69,917
+4,670% +$11.7M
AAPL icon
25
Apple
AAPL
$4.89T
$11.7M 1.18%
304,388
-8
-0% -$310

Similar funds

Shufro Rose & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Shufro Rose & Co held 293 positions worth $995M, up 6.2% from $936M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Shufro Rose & Co's Q3 2017 filing shows 25 new, 75 increased, 95 reduced and 36 closed positions. Its largest new stake was Alleghany Corp: 10,755 shares worth $5.96M. The largest sale was Du Pont De Nemours E I, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q3 2017 buy was Alleghany Corp: 10,755 shares worth $5.96M.
  • Shufro Rose & Co added most to DuPont de Nemours in Q3 2017, an estimated $11.7M increase.
  • Shufro Rose & Co's biggest Q3 2017 reduction was Allergan plc, cutting an estimated $5.47M.
  • Shufro Rose & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $11.3M.
  • Shufro Rose & Co's ten largest holdings make up 31% of its $995M portfolio in Q3 2017.
  • Shufro Rose & Co opened 25 new positions and closed 36 in Q3 2017.
  • Shufro Rose & Co's portfolio value rose 6.2% quarter-over-quarter to $995M.

Based on Shufro Rose & Co's 13F filing for Q3 2017, filed 13 Nov 2017.